Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy

E-ISSN： 1873-4286|22|16|2358-2388

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.16, 2016-05, pp. : 2358-2388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Muscarinic Receptors as Targets for Metronomic Therapy in Breast Cancer

Current Pharmaceutical Design, Vol. 22, Iss. 14, 2016-04 ,pp. : 2170-2177

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging EGFR antagonists for breast cancer

By Lluch Ana Eroles Pilar Perez-Fidalgo Jose-Alejandro

Expert Opinion on Emerging Drugs, Vol. 19, Iss. 2, 2014-06 ,pp. : 165-181

Informa Healthcare

Access to resources Recommend Favorite

Metastatic Cancer Stem Cells: New Molecular Targets for Cancer Therapy

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 11, 2011-11 ,pp. : 1909-1922

Bentham Science Publishers

Access to resources Recommend Favorite

The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer

By Spears Melanie Bartlett John

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 6, 2009-06 ,pp. : 665-674

Informa Healthcare

Access to resources Recommend Favorite

Endocrine Therapy of Breast Cancer

Current Medicinal Chemistry, Vol. 18, Iss. 4, 2011-02 ,pp. : 513-522

Bentham Science Publishers

Access to resources Recommend Favorite